AntihyperglycaemicsBullous pemphigoid: 9 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1694卷 / 1期

关键词：

D O I：

10.1007/s40278-018-43436-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：34 / 34

相关论文

共 50 条

[21] Multiple drugsBullous pemphigoid: 42 case reports
Reactions Weekly, 2017, 1633 (1) : 519 - 519
[22] Teneligliptin/vildagliptinBullous pemphigoid: 3 case reports
Reactions Weekly, 2018, 1723 (1) : 271 - 271
[23] Durvalumab/pembrolizumabBullous pemphigoid: 2 case reports
Reactions Weekly, 2019, 1756 (1) : 142 - 142
[24] Nivolumab/pembrolizumabNonbullous pemphigoid: 4 case reports
Reactions Weekly, 2019, 1776 (1) : 335 - 335
[25] VaccinesBullous pemphigoid in infants: 3 case reports
Reactions Weekly, 2014, 1487 (1) : 34 - 34
[26] Dyshidrosiform Bullous Pemphigoid: Case Reports and Review
Cohen, Philip R.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (01)
[27] Durvalumab/nivolumabBullous pemphigoid: 3 case reports
Reactions Weekly, 2016, 1612 (1) : 80 - 80
[28] Nivolumab/pembrolizumabBullous pemphigoid: 13 case reports
Reactions Weekly, 2021, 1843 (1) : 290 - 290
[29] Antihyperglycaemics and furosemideBullous pemphigoid: 12 case reports
Reactions Weekly, 2019, 1764 (1) : 33 - 33
[30] Multiple drugsBullous pemphigoid: 3 case reports
Reactions Weekly, 2024, 2035 (1) : 298 - 298

← 1 2 3 4 5 →